Reata nets $94.7mm via FOPO

15:40 EDT 28 Jul 2017 | Elsevier Business Intelligence

Reata Pharmaceuticals Inc. (developing therapies that target molecular pathways involved in the regulation of cellular metabo...

Original Article: Reata nets $94.7mm via FOPO


More From BioPortfolio on "Reata nets $94.7mm via FOPO"

Quick Search

Relevant Topics

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...

Nephrology - kidney function
Nephrology is a specialty of medicine and pediatrics that concerns itself with the study of normal kidney function, kidney problems, the treatment of kidney problems and renal replacement therapy (dialysis and kidney transplantation). Systemic conditions...